Literature DB >> 16987877

Epigenetics of autism spectrum disorders.

N Carolyn Schanen1.   

Abstract

The autism spectrum disorders (ASD) comprise a complex group of behaviorally related disorders that are primarily genetic in origin. Involvement of epigenetic regulatory mechanisms in the pathogenesis of ASD has been suggested by the occurrence of ASD in patients with disorders arising from epigenetic mutations (fragile X syndrome) or that involve key epigenetic regulatory factors (Rett syndrome). Moreover, the most common recurrent cytogenetic abnormalities in ASD involve maternally derived duplications of the imprinted domain on chromosome 15q11-13. Thus, parent of origin effects on sharing and linkage to imprinted regions on chromosomes 15q and 7q suggest that these regions warrant specific examination from an epigenetic perspective, particularly because epigenetic modifications do not change the primary genomic sequence, allowing risk epialleles to evade detection using standard screening strategies. This review examines the potential role of epigenetic factors in the etiology of ASD.

Entities:  

Mesh:

Year:  2006        PMID: 16987877     DOI: 10.1093/hmg/ddl213

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  122 in total

Review 1.  Stress and the epigenetic landscape: a link to the pathobiology of human diseases?

Authors:  Sarah E Johnstone; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2010-10-05       Impact factor: 53.242

2.  Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism.

Authors:  Stepan Melnyk; George J Fuchs; Eldon Schulz; Maya Lopez; Stephen G Kahler; Jill J Fussell; Jayne Bellando; Oleksandra Pavliv; Shannon Rose; Lisa Seidel; David W Gaylor; S Jill James
Journal:  J Autism Dev Disord       Date:  2012-03

3.  Age-associated DNA methylation in pediatric populations.

Authors:  Reid S Alisch; Benjamin G Barwick; Pankaj Chopra; Leila K Myrick; Glen A Satten; Karen N Conneely; Stephen T Warren
Journal:  Genome Res       Date:  2012-02-01       Impact factor: 9.043

4.  Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study.

Authors:  Rebecca J Schmidt; Daniel J Tancredi; Sally Ozonoff; Robin L Hansen; Jaana Hartiala; Hooman Allayee; Linda C Schmidt; Flora Tassone; Irva Hertz-Picciotto
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

5.  A longitudinal study of epigenetic variation in twins.

Authors:  Chloe Chung Yi Wong; Avshalom Caspi; Benjamin Williams; Ian W Craig; Renate Houts; Antony Ambler; Terrie E Moffitt; Jonathan Mill
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

6.  Common DNA methylation alterations in multiple brain regions in autism.

Authors:  C Ladd-Acosta; K D Hansen; E Briem; M D Fallin; W E Kaufmann; A P Feinberg
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

7.  The parent-of-origin of the extra X chromosome may differentially affect psychopathology in Klinefelter syndrome.

Authors:  Hilgo Bruining; Sophie van Rijn; Hanna Swaab; Jacques Giltay; Wendy Kates; Martien J H Kas; Herman van Engeland; Leo de Sonneville
Journal:  Biol Psychiatry       Date:  2010-10-29       Impact factor: 13.382

Review 8.  Meta-Analysis of the Association between GABA Receptor Polymorphisms and Autism Spectrum Disorder (ASD).

Authors:  Manijeh Mahdavi; Majid Kheirollahi; Roya Riahi; Fariborz Khorvash; Mehdi Khorrami; Maryam Mirsafaie
Journal:  J Mol Neurosci       Date:  2018-05-03       Impact factor: 3.444

9.  Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers.

Authors:  Mu Yang; Vladimir Zhodzishsky; Jacqueline N Crawley
Journal:  Int J Dev Neurosci       Date:  2007-09-29       Impact factor: 2.457

Review 10.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.